Cathie Wood’s ARK sells Tempus AI stock, buys Scribe Therapeutics Tech 22 h ago 2 sources also on SCTX
Is Tempus AI Stock a Buy After Its 75% Rally? Here's What to Know as the Firm's Legal Chief Files a Trade Tech 33 d ago
Tempus AI's Accounting Chief Just Reported an Insider Transaction. Here's What Long-Term Investors Should Know Tech 33 d ago
Templeton Emerging Markets Investment Trust (TEM) Executes Buyback of 158,413 Shares at 332.16p for Cancellation Deals 16 d ago
Templeton Emerging Markets Investment Trust (TEM) Executes Buyback, Cancels 336,430 Shares at 330.59p Each Markets 17 d ago
Templeton Emerging Markets Investment Trust (TEM) Cancels 571,009 Shares at 321.44p in Latest Buyback Markets 21 d ago
Tempus AI (TEM) Has a $75 Goldman Sachs Target, But Its Data Business Faces a Bigger Test Tech 2 d ago also on GS
Tempus AI Got an $80 Target and 28% Upside Call. Is Wall Street Underestimating Its Healthcare Data Moat? Tech 21 d ago
Tempus AI (TEM) Jumped on Moderna’s Melanoma Win. Did its $1.5B Personalis Acquisition Just Get Validated? Deals 28 d ago also on MRNA PSNL
Tempus AI's Diagnostics Chief Filed Stock Sales Spanning a Volatile Week. Here's What Happened Tech 33 d ago
Tempus AI's CEO Sold $6.6 Million in Stock the Day Before a Huge Rally. Here's What to Know Tech 33 d ago